Loading ETF profile…
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| MRNA | Moderna Inc | 1.88% | $1.62M |
| PGEN | Precigen Inc | 1.79% | $1.55M |
| AGIO | Agios Pharmaceuticals Inc | 1.74% | $1.50M |
| RARE | Ultragenyx Pharmaceutical Inc | 1.70% | $1.47M |
| RYTM | Rhythm Pharmaceuticals Inc | 1.68% | $1.45M |
| CYTK | Cytokinetics Inc | 1.67% | $1.45M |
| MIRM | Mirum Pharmaceuticals Inc | 1.67% | $1.44M |
| IBRX | ImmunityBio Inc | 1.66% | $1.44M |
| LGND | Ligand Pharmaceuticals Inc | 1.65% | $1.43M |
| KURA | Kura Oncology Inc | 1.63% | $1.41M |
| ASND | Ascendis Pharma A/S | 1.63% | $1.41M |
| KNSA | Kiniksa Pharmaceuticals International Plc | 1.62% | $1.40M |
| DNLI | Denali Therapeutics Inc | 1.61% | $1.39M |
| ACAD | ACADIA Pharmaceuticals Inc | 1.61% | $1.39M |
| SNDX | Syndax Pharmaceuticals Inc | 1.61% | $1.39M |
| KRYS | Krystal Biotech Inc | 1.60% | $1.38M |
| RIGL | Rigel Pharmaceuticals Inc | 1.60% | $1.38M |
| IRWD | Ironwood Pharmaceuticals Inc | 1.59% | $1.37M |
| ROIV | Roivant Sciences Ltd | 1.56% | $1.34M |
| NUVB | Nuvation Bio Inc | 1.53% | $1.33M |
| XERS | Xeris Biopharma Holdings Inc | 1.53% | $1.33M |
| OMER | Omeros Corp | 1.53% | $1.32M |
| CRSP | CRISPR Therapeutics AG | 1.52% | $1.32M |
| GERN | Geron Corp | 1.52% | $1.31M |
| TGTX | TG Therapeutics Inc | 1.51% | $1.31M |